USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Aviv Biomedical, Inc.
Address:
750 VASSAR AVE
LAKEWOOD, NJ
Phone:
(732) 370-1300
URL:
N/A
EIN:
222308040
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $170,158.00 1
SBIR Phase II $826,992.00 1
STTR Phase I $99,973.00 1

Award List:

Advanced Absorbance Detection for the AUC

Award Year / Program / Phase:
2005 / STTR / Phase I
Award Amount:
$99,973.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF NEW HAMPSHIRE
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The purpose of this STTR is to produce a commercially available rapid-scan absorbance optical detection system for XLA/I analytical ultracentrifuges. The currently available absorbance optical system provided by the analytical ultracentrifuge manufacturer is not… More

Point-of Care System for Determination of Bilirubin Capacity in Neonates

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$170,158.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Human serum albumin is capable of binding bilirubin with high affinity, thus sequestering it and mitigat- ing its harmful neurological effects in jaundiced newborns. Despite considerable work indicating that the level o f bilirubin in the blood relative to the… More

Point-of Care System for Determination of Bilirubin Capacity in Neonates

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$826,992.00
Agency:
HHS
Principal Investigator:
Glen D. Ramsay – 732-370-1300
Abstract:
DESCRIPTION (provided by applicant): Uncontrolled hyperbilirubinemia (jaundice) in neonates has long been known to lead to neurological dysfunction including irreversible athetoid cerebral palsy with speech, ocular and hearing impairments, and even death.Contemporary management is based upon… More